A draft guidance on multi-regional clinical trials would make it harder for pharmaceutical companies to get innovative drugs approved in the PRC. If implemented, the new rules could lead to confusion and delays

A draft guidance on multi-regional clinical trials would make it harder for pharmaceutical companies to get innovative drugs approved in the PRC. If implemented, the new rules could lead to confusion and delays

Foreign investment in nursing homes has been encouraged, the CIRC listed the means for insurance companies to increase capital and the SAIC set rules for group buying websites

The revision abolishes the requirement for prior CSRC approval of a takeover offer.

This week the Range Rover Evoque was copied by Chinese LandWind, Microsoft got fined US$140 million for tax evasion, the NDRC considered lifting price caps on drugs and Tencent signed a deal with HBO

Minor changes were made in Articles 19, 71 and 78.

The CSRC has issued provisions on the administration of securities companies, the CCPIT produced new Rules for CMAC and the State Council set out a draft framework for investments by the the National Social Security Fund

This week CGN Power aimed to raise US$3.16 billion in its HK IPO, the China Maritime Arbitration Commission opened an office in Hong Kong, an independent IP office was launched in Shanghai and China signed a US$12 billion rail deal with Nigeria

The new CIETAC Arbitration Rules provide for emergency action, clarify the Hong Kong centre's role and expand use of the summary procedure. These changes show CIETAC is keeping up with global standards